Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Osteoporosis

Free Subscription 28.10.2019 3 J Clin Endocrinol Metab 2 J Rheumatol 5 Osteoporos Int

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

J Clin Endocrinol Metab

1. SUGIYAMA T
   Letter to the Editor: "Exercise mitigates bone loss in women with severe obesity after Roux-en-Y gastric bypass: a randomized controlled trial".
   J Clin Endocrinol Metab. 2019 Oct 23. pii: 5602688. doi: 10.1210.
   PubMed     Text format    
   
   
2. MURAI IH, Roschel H, Gualano B
   Response to Letter to the Editor: "Exercise mitigates bone loss in women with severe obesity after Roux-en-Y gastric bypass: a randomized controlled trial".
   J Clin Endocrinol Metab. 2019 Oct 23. pii: 5602687. doi: 10.1210.
   PubMed     Text format    
   
   
3. MERLOTTI D, Rendina D, Muscariello R, Picchioni T, et al
   PREVENTIVE ROLE OF VITAMIN D SUPPLEMENTATION FOR ACUTE PHASE REACTION AFTER BISPHOSPHONATE INFUSION IN PAGET'S DISEASE.
   J Clin Endocrinol Metab. 2019 Oct 22. pii: 5601913. doi: 10.1210.
   PubMed     Text format     Abstract available
   
   

   
   J Rheumatol

4. BEST JH, Kong AM, Lenhart GM, Sarsour K, et al
   Association Between Glucocorticoid Exposure and Healthcare Expenditures for Potential Glucocorticoid-related Adverse Events in Patients with Rheumatoid Arthritis.
   J Rheumatol. 2018 Jan 15. pii: jrheum.170418. doi: 10.3899/jrheum.170418.
   PubMed     Text format     Abstract available
   
   
5. LAU AN, Wong-Pack M, Rodjanapiches R, Ioannidis G, et al
   Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting.
   J Rheumatol. 2017 Nov 15. pii: jrheum.161270. doi: 10.3899/jrheum.161270.
   PubMed     Text format     Abstract available
   
   

   
   Osteoporos Int

6. LESLIE WD
   Bisphosphonates and lower mortality risk: when it sounds to be good to be true ....
   Osteoporos Int. 2019 Oct 19. pii: 10.1007/s00198-019-05157.
   PubMed     Text format    
   
   
7. WU CH, Kao IJ, Hung WC, Lin SC, et al
   Economic impact and cost-effectiveness of fracture liaison services: a systematic review of the literature.
   Osteoporos Int. 2018 Feb 19. pii: 10.1007/s00198-018-4411.
   PubMed     Text format     Abstract available
   
   
8. DELL R, Greene D
   A proposal for an atypical femur fracture treatment and prevention clinical practice guideline.
   Osteoporos Int. 2018 Apr 19. pii: 10.1007/s00198-018-4506.
   PubMed     Text format     Abstract available
   
   
9. GEUSENS P, van den Bergh J
   Comments on Kanis et al.: Characteristics of recurrent fractures.
   Osteoporos Int. 2018 Dec 18. pii: 10.1007/s00198-018-4735.
   PubMed     Text format    
   
   
10. KENDLER DL, Bone HG, Massari F, Gielen E, et al
    Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab.
    Osteoporos Int. 2019 Oct 18. pii: 10.1007/s00198-019-05146.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Osteoporosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: